Published in Infect Immun on January 01, 1984
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Pathophysiology of Campylobacter enteritis. Microbiol Rev (1986) 4.94
Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence. Infect Immun (1986) 2.84
Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog (2005) 2.71
Isolation and characterization of the cytoplasmic and outer membranes of the Legionnaires' disease bacterium (Legionella pneumophila). J Exp Med (1985) 2.37
Structural and antigenic heterogeneity of lipopolysaccharides of Campylobacter jejuni and Campylobacter coli. Infect Immun (1984) 2.23
Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b. Infect Immun (1987) 2.06
Structural and antigenic properties of lipopolysaccharides from serotype reference strains of Campylobacter jejuni. Infect Immun (1987) 1.94
Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71
Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae. Infect Immun (1987) 1.59
Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features. J Bacteriol (1990) 1.48
Phenotypic variation and modulation in Bordetella bronchiseptica. Infect Immun (1984) 1.36
Role of Bordetella O antigen in respiratory tract infection. Infect Immun (2003) 1.32
Siderophore production and membrane alterations by Bordetella pertussis in response to iron starvation. Infect Immun (1992) 1.26
Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide. Infect Immun (1994) 1.12
Production and characterization of monoclonal antibodies directed against Bordetella pertussis lipopolysaccharide. J Clin Microbiol (1988) 1.11
Identification and cloning of waaF (rfaF) from Bordetella pertussis and use to generate mutants of Bordetella spp. with deep rough lipopolysaccharide. J Bacteriol (1998) 1.11
Heat-modifiable envelope proteins of Bordetella pertussis. Infect Immun (1986) 1.10
The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect Immun (1998) 1.10
A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis. Infect Immun (1992) 1.10
Structure of the terminal reducing heptasaccharide of polysaccharide 1 isolated from the Bordetella pertussis endotoxin. J Bacteriol (1984) 1.08
Comparisons of Pasteurella multocida lipopolysaccharides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis to determine relationship between group B and E hemorrhagic septicemia strains and serologically related group A strains. J Clin Microbiol (1990) 1.07
Phenotypic phase variation in Haemophilus somnus lipooligosaccharide during bovine pneumonia and after in vitro passage. Infect Immun (1992) 1.07
The relationship between the serogroup antigen and lipopolysaccharide of Legionella pneumophila. J Hyg (Lond) (1986) 1.07
Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis. Infect Immun (2006) 1.07
Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis. Infect Immun (1992) 1.05
Expression of lipopolysaccharide O antigen in Escherichia coli K-12 hybrids containing plasmid and chromosomal genes from Shigella dysenteriae 1. Infect Immun (1984) 1.03
Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulation. Infect Immun (1986) 1.02
Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infect Immun (2000) 0.99
A mutation in the Neisseria gonorrhoeae rfaD homolog results in altered lipooligosaccharide expression. J Bacteriol (1995) 0.98
Structural characterization of the lipid A of Bordetella pertussis 1414 endotoxin. J Bacteriol (1994) 0.95
Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes. Infect Immun (2001) 0.93
Antigenic evidence for simultaneous expression of two different lipooligosaccharides by some strains of Haemophilus influenzae type b. Infect Immun (1989) 0.93
Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities. Infect Immun (2004) 0.89
A role for lipopolysaccharide in turkey tracheal colonization by Bordetella avium as demonstrated in vivo and in vitro. Mol Microbiol (2000) 0.87
Identification of a novel lipopolysaccharide core biosynthesis gene cluster in Bordetella pertussis, and influence of core structure and lipid A glucosamine substitution on endotoxic activity. Infect Immun (2009) 0.87
Isolation and characterization of Bordetella pertussis phenotype variants capable of growing on nutrient agar: comparison with phases III and IV. Infect Immun (1984) 0.87
Toward a new vaccine for pertussis. Proc Natl Acad Sci U S A (2014) 0.83
Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis. Clin Diagn Lab Immunol (2001) 0.83
Use of bispecific antibodies in molecular velcro assays whose specificity approaches the theoretical limit of immunodetection for Bordetella pertussis. Clin Diagn Lab Immunol (2004) 0.81
Identification, characterization, and variation in expression of two serologically distinct O-antigen epitopes in lipopolysaccharides of Campylobacter fetus serotype A strains. Infect Immun (2001) 0.79
A critical role for the TLR signaling adapter Mal in alveolar macrophage-mediated protection against Bordetella pertussis. Mucosal Immunol (2014) 0.76
Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells. Infect Immun (2014) 0.76
Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic. J Biol Chem (2010) 0.76
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J Immunol (1975) 47.77
A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem (1982) 36.39
Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol (1983) 25.26
A new method for the extraction of R lipopolysaccharides. Eur J Biochem (1969) 22.41
A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol (1970) 8.89
Structure and function of the cell envelope of gram-negative bacteria. Bacteriol Rev (1974) 7.42
The use of Tween 20 as a blocking agent in the immunological detection of proteins transferred to nitrocellulose membranes. J Immunol Methods (1982) 6.36
Size heterogeneity of Salmonella typhimurium lipopolysaccharides in outer membranes and culture supernatant membrane fragments. J Bacteriol (1980) 4.84
Studies on hemagglutination and hemolysis by escherichia coli antisera. J Exp Med (1952) 3.56
Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli. J Immunol (1972) 2.89
Reactions after pertussis vaccine: a manufacturer's experiences and difficulties since 1964. Br Med J (1978) 2.54
Isolation and characterization of isogenic pairs of domed hemolytic and flat nonhemolytic colony types of Bordetella pertussis. Infect Immun (1982) 2.47
Studies on Haemophilus pertussis. I. Antigen structure of H. pertussis and its phases. Kitasato Arch Exp Med (1953) 1.68
Isolation of two protein-free and chemically different lipopolysaccharides from Bordetella pertussis phenol-extracted endotoxin. J Bacteriol (1980) 1.59
Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis Suppl (1982) 1.56
Specific lipopolysaccharides of Bordetella. Biochem J (1960) 1.53
The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice. J Gen Microbiol (1972) 1.34
A novel type of endotoxin structure present in Bordetella pertussis. Isolation of two different polysaccharides bound to lipid A. Eur J Biochem (1978) 1.32
Studies on Haemophilis pertussis. III. Some properties of each phase of H. pertussis. Kitasato Arch Exp Med (1954) 1.30
3-Deoxy-2-octulosonic acid 5-phosphate: a component of the endotoxin of Bordetella pertussis. Eur J Biochem (1975) 1.12
Immunochemical studies on the lipopolysaccharides of Bordetella pertussis. Can J Microbiol (1973) 1.10
Chemical and biological properties of the purified O antigen of Bordetella pertussis. Jpn J Microbiol (1970) 1.03
Increased histamine sensitivity in mice after administration of endotoxins. Infect Immun (1977) 0.99
[Structure and biological activity of Bordetella pertussis endotoxin (proceedings)]. Zentralbl Bakteriol Orig A (1976) 0.95
Isolation and characterization of Bordetella pertussis phenotype variants capable of growing on nutrient agar: comparison with phases III and IV. Infect Immun (1984) 0.87
Availability and specificity of lipopolysaccharide on the surface of 56 degrees C heated Bordetella pertussis. Can J Microbiol (1973) 0.86
Taxonomic distribution of the antigen eliciting bactericidal antibody for Bordetella pertussis. J Gen Microbiol (1975) 0.83
Attempts at analysis of toxicity of pertussis vaccine. III. Effects of endotoxin on leukocytosis in mice due to lymphocytosis-promoting factor and reference preparations for determination of lymphocytosis-promoting factor. Jpn J Med Sci Biol (1978) 0.82
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Use of pulsed-field gel electrophoresis for epidemiological study of Bordetella pertussis in a whooping cough outbreak. J Clin Microbiol (1994) 4.13
Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect Immun (1989) 3.27
Isolation and characterization of isogenic pairs of domed hemolytic and flat nonhemolytic colony types of Bordetella pertussis. Infect Immun (1982) 2.47
Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J Infect Dis (1980) 2.05
Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens. Infect Immun (1982) 1.96
Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect Immun (1992) 1.85
Bordetella parapertussis invasion of HeLa 229 cells and human respiratory epithelial cells in primary culture. Infect Immun (1989) 1.78
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. J Clin Microbiol (1993) 1.39
Phenotypic variation and modulation in Bordetella bronchiseptica. Infect Immun (1984) 1.36
Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations. Infect Immun (1982) 1.18
Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose. Infect Immun (1987) 1.14
Use of glycosyltransferases to restore pertussis toxin receptor activity to asialoagalactofetuin. J Biol Chem (1988) 1.10
Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis. Infect Immun (1992) 1.05
The structure of the nonreducing terminal groups in the O-specific polysaccharides from two strains of Bordetella bronchiseptica. Eur J Biochem (2000) 1.02
Identification of two bvg-repressed surface proteins of Bordetella pertussis. Infect Immun (1995) 0.95
Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect Immun (2005) 0.95
Tn5-induced lipopolysaccharide mutations in Bordetella pertussis that affect outer membrane function. Microbiology (1997) 0.92
Lectinlike properties of pertussis toxin. Infect Immun (1989) 0.90
Evaluation and validation of a monoclonal immunofluorescent reagent for direct detection of Bordetella pertussis. J Clin Microbiol (1995) 0.88
Temperature-sensitive mutants in rfaI and rfaJ, genes for galactosyltransferase I and glucosyltransferase II, for synthesis of lipopolysaccharide in Salmonella typhimurium. Can J Microbiol (1985) 0.88
Isolation and characterization of Bordetella pertussis phenotype variants capable of growing on nutrient agar: comparison with phases III and IV. Infect Immun (1984) 0.87
Effect of proteolytic enzymes, storage and reduction on the structure and biological activity of pertussigen, a toxin from Bordetella pertussis. Dev Biol Stand (1985) 0.86
Phorbol myristate acetate inhibits HeLa 229 invasion by Bordetella pertussis and other invasive bacterial pathogens. Infect Immun (1990) 0.86
Analysis of Mycobacterium avium complex isolates from blood samples of AIDS patients by pulsed-field gel electrophoresis. J Clin Microbiol (2003) 0.84
Use of bispecific antibodies in molecular velcro assays whose specificity approaches the theoretical limit of immunodetection for Bordetella pertussis. Clin Diagn Lab Immunol (2004) 0.81
An improved immunofluorescent reagent for rapid, direct detection of Bordetella pertussis. Can J Infect Dis (1995) 0.75